Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Cx43 can form functional channels at the nuclear envelope and modulate gene expression in cardiac cells

  • Martins-Marques, Tânia
  • Witschas, Katja
  • Ribeiro, Ilda
  • Zuzarte, Monica
  • Catarino, Steve
  • Ribeiro-Rodrigues, Teresa M
  • Aasen, Trond
Conexina 43; Expresión génica; Translocación nuclear, Connexina 43; Expressió gènica; Translocació nuclear, Connexin 43; Gene expression; Nuclear translocation, Classically associated with gap junction-mediated intercellular communication, connexin43 (Cx43) is increasingly recognized to possess non-canonical biological functions, including gene expression regulation. However, the mechanisms governing the localization and role played by Cx43 in the nucleus, namely in transcription modulation, remain unknown. Using comprehensive and complementary approaches encompassing biochemical assays, super-resolution and immunogold transmission electron microscopy, we demonstrate that Cx43 localizes to the nuclear envelope of different cell types and in cardiac tissue. We show that translocation of Cx43 to the nucleus relies on Importin-β, and that Cx43 significantly impacts the cellular transcriptome, likely by interacting with transcriptional regulators. In vitro patch-clamp recordings from HEK293 and adult primary cardiomyocytes demonstrate that Cx43 forms active channels at the nuclear envelope, providing evidence that Cx43 can participate in nucleocytoplasmic shuttling of small molecules. The accumulation of nuclear Cx43 during myogenic differentiation of cardiomyoblasts is suggested to modulate expression of genes implicated in this process. Altogether, our study provides new evidence for further defining the biological roles of nuclear Cx43, namely in cardiac pathophysiology., This work was supported by the European Regional Development Fund (ERDF) through the Operational Program for Competitiveness Factors (COMPETE) under the projects HealthyAging2020 CENTRO-01-0145-FEDER-000012-N2323, CENTRO-01-0145-FEDER-032179, CENTRO-01-0145-FEDER-032414, EXPL/MED-OUT/0590/2021, UIDB/04539/2020 and PPBI-Portuguese Platform of BioImaging (POCI-01-0145-FEDER-022122). This work was also supported by the European Union's Horizon 2020 research and innovation programme under grant agreement MIA-Portugal no. 857524 and the Comissão de Coordenação da Região Centro (CCDRC) through the Centro2020 Program. T.A. acknowledges funding from Instituto de Salud Carlos III, grant PI16/00772 co-financed by the ERDF, and Fundación Científica Asociación Española Contra el Cáncer (IDEAS20039AASE). This work used the platforms of the Grenoble Instruct-ERIC center (ISBG; UAR 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-0005-02) and GRAL, financed within the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003), and the Microscopy and Bioimaging Lab (iLAB) at the Faculty of Medicine of the University of Coimbra (Coimbra, Portugal). The IBS Electron Microscope facility is supported by the Auvergne Rhône-Alpes Region, the Fonds Feder, the Fondation pour la Recherche Médicale and GIS-IBiSA. Super-resolution microscopy experiments benefited from access to CBI/IGBMC (Illkirch, France) and were supported by FRISBI (ANR-10-INBS-0005). Financial support was provided by Instruct-ERIC (PID 14677).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Clinical implications of intratumor heterogeneity: challenges and opportunities

  • Ramon y Cajal Agüeras, Santiago
  • Sese Faustino, Marta
  • Capdevila Castillo, Clàudia
  • Aasen, Trond
  • Mattos Arruda, Leticia de
  • Diaz-Cano, Salvador J.
  • Hernandez Losa, Javier
  • Castellví Vives, Josep
Heterogeneidad intratumoral; Inteligencia artificial; Terapias antitumorales, Heterogeneïtat intratumoral; Intel·ligència artificial; Teràpies antitumorals, Intratumor heterogeneity; Artificial intelligence; Antitumor therapeutics, In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors., SRYC received support from Fondo de Investigaciones Sanitarias (PI14/01320 and PI17/02247), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057), CIBERONC (CB16/12/00363), and Generalitat de Catalunya (AGAUR, 2017 SGR 1799 and 2014 SGR 1131). TA received support from Instituto de Salud Carlos III (grants PI16/00772 and CPII16/00042), co-financed by the European Regional Development Fund (ERDF).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo

  • Sesé, Marta|||0000-0003-1473-4833
  • Fuentes Varela, Pedro|||0000-0001-8471-0197
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Bejar Serrano, Eva|||0000-0002-1843-3010
  • McGrail, Kimberley|||0000-0001-7227-7306
  • Thomas, George|||0000-0002-1236-1714
  • Aasen, Trond|||0000-0003-0763-2695
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Breast cancer is the most prevalent malignancy in women and there is an urgent need for new therapeutic drugs targeting aggressive and metastatic subtypes, such as hormone-refractory triple-negative breast cancer (TNBC). Control of protein synthesis is vital to cell growth and tumour progression and permits increased resistance to therapy and cellular stress. Hypoxic cancer cells attain invasive and metastatic properties and chemotherapy resistance, but the regulation and role of protein synthesis in this setting is poorly understood. We performed a polysomal RNA-Seq screen in non-malignant breast epithelial (MCF10A) and TNBC (MDA-MB-231) cells exposed to normoxic or hypoxic conditions and/or treated with an mTOR pathway inhibitor. Analysis of both the transcriptome and the translatome identified mRNA transcripts translationally activated or repressed by hypoxia in an mTOR-dependent or -independent manner. Integrin beta 3 (ITGB3) was translationally activated in hypoxia and its knockdown increased apoptosis and reduced survival and migration, particularly under hypoxic conditions. Moreover, ITGB3 was required for sustained TGF-β pathway activation and for the induction of Snail and associated epithelial-mesenchymal transition markers. ITGB3 downregulation significantly reduced lung metastasis and improved overall survival in mice. Collectively, these data suggest that ITGB3 is translationally activated in hypoxia and regulates malignant features, including epithelial-mesenchymal transition and cell migration, through the TGF-β pathway, revealing a novel angle for the treatment of therapy-resistant hypoxic tumours.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Insight into the role and regulation of gap junction genes in lung cancer and identification of nuclear Cx43 as a putative biomarker of poor prognosis

  • Aasen, Trond|||0000-0003-0763-2695
  • Sansano, Irene|||0000-0003-0188-5210
  • Montero, María Ángeles
  • Romagosa, Cleofé
  • Temprana-Salvador, Jordi|||0000-0001-9516-1680
  • Martinez-Marti, Alex|||0000-0002-6714-9526
  • Moliné, Teresa|||0000-0003-4912-5114
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Direct intercellular communication, mediated by gap junctions formed by the connexin transmembrane protein family, is frequently dysregulated in cancer. Connexins have been described as tumour suppressors, but emerging evidence suggests that they can also act as tumour promoters. This feature is connexin- and tissue-specific and may be mediated by complex signalling pathways through gap junctions or hemichannels or by completely junction-independent events. Lung cancer is the number one cancer in terms of mortality worldwide, and novel biomarkers and therapeutic targets are urgently needed. Our objective was to gain a better understanding of connexins in this setting. We used several in silico tools to analyse TCGA data in order to compare connexin mRNA expression between healthy lung tissue and lung tumours and correlated these results with gene methylation patterns. Using Kaplan-Meier plotter tools, we analysed a microarray dataset and an RNA-seq dataset of non-small cell lung tumours in order to correlate connexin expression with patient prognosis. We found that connexin mRNA expression is frequently either upregulated or downregulated in lung tumours. This correlated with both good and poor prognosis (overall survival) in a clear connexin isoform-dependent manner. These associations were strongly influenced by the histological subtype (adenocarcinoma versus squamous cell carcinoma). We present an overview of all connexins but particularly focus on four isoforms implicated in lung cancer: Cx26, Cx30.3, Cx32 and Cx43. We further analysed the protein expression and localization of Cx43 in a series of 73 human lung tumours. We identified a subset of tumours that exhibited a unique strong nuclear Cx43 expression pattern that predicted worse overall survival (p = 0.014). Upon sub-stratification, the prognostic value remained highly significant in the adenocarcinoma subtype (p = 0.002) but not in the squamous carcinoma subtype (p = 0.578). This finding highlights the importance of analysis of connexin expression at the protein level, particularly the subcellular localization. Elucidation of the underlying pathways regulating Cx43 localization may provide for novel therapeutic opportunities.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Clinical implications of intratumor heterogeneity, challenges and opportunities

  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Sesé, Marta|||0000-0003-1473-4833
  • Capdevila, Claudia
  • Aasen, Trond|||0000-0003-0763-2695
  • De Mattos-Arruda, Leticia|||0000-0002-4992-3645
  • Diaz-Cano, Salvador J.
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Castellvi, Josep|||0000-0001-5745-9996
In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cx43 and Associated Cell Signaling Pathways Regulate Tunneling Nanotubes in Breast Cancer Cells

  • Tishchenko, Alexander
  • Azorín, Daniel D.
  • Vidal-Brime, Laia
  • José Muñoz, María
  • Jiménez Arenas, Pol
  • Pearce, Christopher
  • Girao, Henrique|||0000-0002-5786-8447
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Aasen, Trond|||0000-0003-0763-2695
Connexin 43 (Cx43) forms gap junctions that mediate the direct intercellular diffusion of ions and small molecules between adjacent cells. Cx43 displays both pro- and anti-tumorigenic properties, but the mechanisms underlying these characteristics are not fully understood. Tunneling nanotubes (TNTs) are long and thin membrane projections that connect cells, facilitating the exchange of not only small molecules, but also larger proteins, organelles, bacteria, and viruses. Typically, TNTs exhibit increased formation under conditions of cellular stress and are more prominent in cancer cells, where they are generally thought to be pro-metastatic and to provide growth and survival advantages. Cx43 has been described in TNTs, where it is thought to regulate small molecule diffusion through gap junctions. Here, we developed a high-fidelity CRISPR/Cas9 system to knockout (KO) Cx43. We found that the loss of Cx43 expression was associated with significantly reduced TNT length and number in breast cancer cell lines. Notably, secreted factors present in conditioned medium stimulated TNTs more potently when derived from Cx43-expressing cells than from KO cells. Moreover, TNT formation was significantly induced by the inhibition of several key cancer signaling pathways that both regulate Cx43 and are regulated by Cx43, including RhoA kinase (ROCK), protein kinase A (PKA), focal adhesion kinase (FAK), and p38. Intriguingly, the drug-induced stimulation of TNTs was more potent in Cx43 KO cells than in wild-type (WT) cells. In conclusion, this work describes a novel non-canonical role for Cx43 in regulating TNTs, identifies key cancer signaling pathways that regulate TNTs in this setting, and provides mechanistic insight into a pro-tumorigenic role of Cx43 in cancer.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Connexins, Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease

  • Aasen, Trond|||0000-0003-0763-2695
  • Johnstone, Scott|||0000-0003-1920-5033
  • Vidal-Brime, Laia
  • Lynn, K. Sabrina
  • Koval, Michael|||0000-0002-5422-5614
Connexins are tetraspan transmembrane proteins that form gap junctions and facilitate direct intercellular communication, a critical feature for the development, function, and homeostasis of tissues and organs. In addition, a growing number of gap junction-independent functions are being ascribed to these proteins. The connexin gene family is under extensive regulation at the transcriptional and post-transcriptional level, and undergoes numerous modifications at the protein level, including phosphorylation, which ultimately affects their trafficking, stability, and function. Here, we summarize these key regulatory events, with emphasis on how these affect connexin multifunctionality in health and disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis

  • Varela-Eirín, Marta
  • Varela-Vázquez, Adrián
  • Guitián-Caamaño, Amanda
  • Paíno, Carlos Luis
  • Mato, Virginia
  • Largo, Raquel|||0000-0001-6525-2944
  • Aasen, Trond|||0000-0003-0763-2695
  • Tabernero, Arantxa|||0000-0001-6302-6134
  • Fonseca, Eduardo|||0000-0002-8048-2681
  • Kandouz, Mustapha
  • Caeiro Rey, José Ramón
  • Blanco, Alfonso
  • Mayán, María D.
Osteoarthritis (OA), a chronic disease characterized by articular cartilage degeneration, is a leading cause of disability and pain worldwide. In OA, chondrocytes in cartilage undergo phenotypic changes and senescence, restricting cartilage regeneration and favouring disease progression. Similar to other wound-healing disorders, chondrocytes from OA patients show a chronic increase in the gap junction channel protein connexin43 (Cx43), which regulates signal transduction through the exchange of elements or recruitment/release of signalling factors. Although immature or stem-like cells are present in cartilage from OA patients, their origin and role in disease progression are unknown. In this study, we found that Cx43 acts as a positive regulator of chondrocyte-mesenchymal transition. Overactive Cx43 largely maintains the immature phenotype by increasing nuclear translocation of Twist-1 and tissue remodelling and proinflammatory agents, such as MMPs and IL-1β, which in turn cause cellular senescence through upregulation of p53, p16 INK4a and NF-κB, contributing to the senescence-associated secretory phenotype (SASP). Downregulation of either Cx43 by CRISPR/Cas9 or Cx43-mediated gap junctional intercellular communication (GJIC) by carbenoxolone treatment triggered rediferentiation of osteoarthritic chondrocytes into a more differentiated state, associated with decreased synthesis of MMPs and proinflammatory factors, and reduced senescence. We have identified causal Cx43-sensitive circuit in chondrocytes that regulates dedifferentiation, redifferentiation and senescence. We propose that chondrocytes undergo chondrocyte-mesenchymal transition where increased Cx43-mediated GJIC during OA facilitates Twist-1 nuclear translocation as a novel mechanism involved in OA progression. These findings support the use of Cx43 as an appropriate therapeutic target to halt OA progression and to promote cartilage regeneration.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Clinical implications of intratumor heterogeneity: challenges and opportunities

  • Ramon y Cajal Agüeras, Santiago
  • Sese Faustino, Marta
  • Capdevila Castillo, Clàudia
  • Aasen, Trond
  • Mattos Arruda, Leticia de
  • Diaz-Cano, Salvador J.
  • Hernandez Losa, Javier
  • Castellví Vives, Josep
Heterogeneidad intratumoral; Inteligencia artificial; Terapias antitumorales, Heterogeneïtat intratumoral; Intel·ligència artificial; Teràpies antitumorals, Intratumor heterogeneity; Artificial intelligence; Antitumor therapeutics, In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors., SRYC received support from Fondo de Investigaciones Sanitarias (PI14/01320 and PI17/02247), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057), CIBERONC (CB16/12/00363), and Generalitat de Catalunya (AGAUR, 2017 SGR 1799 and 2014 SGR 1131). TA received support from Instituto de Salud Carlos III (grants PI16/00772 and CPII16/00042), co-financed by the European Regional Development Fund (ERDF).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Cx43 can form functional channels at the nuclear envelope and modulate gene expression in cardiac cells

  • Martins-Marques, Tânia
  • Witschas, Katja
  • Ribeiro, Ilda
  • Zuzarte, Monica
  • Catarino, Steve
  • Ribeiro-Rodrigues, Teresa M
  • Aasen, Trond
Conexina 43; Expresión génica; Translocación nuclear, Connexina 43; Expressió gènica; Translocació nuclear, Connexin 43; Gene expression; Nuclear translocation, Classically associated with gap junction-mediated intercellular communication, connexin43 (Cx43) is increasingly recognized to possess non-canonical biological functions, including gene expression regulation. However, the mechanisms governing the localization and role played by Cx43 in the nucleus, namely in transcription modulation, remain unknown. Using comprehensive and complementary approaches encompassing biochemical assays, super-resolution and immunogold transmission electron microscopy, we demonstrate that Cx43 localizes to the nuclear envelope of different cell types and in cardiac tissue. We show that translocation of Cx43 to the nucleus relies on Importin-β, and that Cx43 significantly impacts the cellular transcriptome, likely by interacting with transcriptional regulators. In vitro patch-clamp recordings from HEK293 and adult primary cardiomyocytes demonstrate that Cx43 forms active channels at the nuclear envelope, providing evidence that Cx43 can participate in nucleocytoplasmic shuttling of small molecules. The accumulation of nuclear Cx43 during myogenic differentiation of cardiomyoblasts is suggested to modulate expression of genes implicated in this process. Altogether, our study provides new evidence for further defining the biological roles of nuclear Cx43, namely in cardiac pathophysiology., This work was supported by the European Regional Development Fund (ERDF) through the Operational Program for Competitiveness Factors (COMPETE) under the projects HealthyAging2020 CENTRO-01-0145-FEDER-000012-N2323, CENTRO-01-0145-FEDER-032179, CENTRO-01-0145-FEDER-032414, EXPL/MED-OUT/0590/2021, UIDB/04539/2020 and PPBI-Portuguese Platform of BioImaging (POCI-01-0145-FEDER-022122). This work was also supported by the European Union's Horizon 2020 research and innovation programme under grant agreement MIA-Portugal no. 857524 and the Comissão de Coordenação da Região Centro (CCDRC) through the Centro2020 Program. T.A. acknowledges funding from Instituto de Salud Carlos III, grant PI16/00772 co-financed by the ERDF, and Fundación Científica Asociación Española Contra el Cáncer (IDEAS20039AASE). This work used the platforms of the Grenoble Instruct-ERIC center (ISBG; UAR 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-0005-02) and GRAL, financed within the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003), and the Microscopy and Bioimaging Lab (iLAB) at the Faculty of Medicine of the University of Coimbra (Coimbra, Portugal). The IBS Electron Microscope facility is supported by the Auvergne Rhône-Alpes Region, the Fonds Feder, the Fondation pour la Recherche Médicale and GIS-IBiSA. Super-resolution microscopy experiments benefited from access to CBI/IGBMC (Illkirch, France) and were supported by FRISBI (ANR-10-INBS-0005). Financial support was provided by Instruct-ERIC (PID 14677).